Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1982 1
1983 1
1987 1
1988 1
1990 1
1991 1
1992 5
1993 2
1994 3
1995 4
1998 2
1999 1
2000 6
2001 4
2002 9
2003 8
2004 9
2005 5
2006 8
2007 5
2008 5
2009 8
2010 20
2011 13
2012 17
2013 23
2014 25
2015 25
2016 26
2017 12
2018 19
2019 20
2020 18
2021 12
2022 20
2023 14
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E, Rutakingirwa MK, Ssebambulidde K, Tugume L, Rhein J, Boulware DR, Mwandumba HC, Moyo M, Mzinganjira H, Kanyama C, Hosseinipour MC, Chawinga C, Meintjes G, Schutz C, Comins K, Singh A, Muzoora C, Jjunju S, Nuwagira E, Mosepele M, Leeme T, Siamisang K, Ndhlovu CE, Hlupeni A, Mutata C, van Widenfelt E, Chen T, Wang D, Hope W, Boyer-Chammard T, Loyse A, Molloy SF, Youssouf N, Lortholary O, Lalloo DG, Jaffar S, Harrison TS; Ambition Study Group. Jarvis JN, et al. Among authors: molloy sf. N Engl J Med. 2022 Mar 24;386(12):1109-1120. doi: 10.1056/NEJMoa2111904. N Engl J Med. 2022. PMID: 35320642 Free PMC article. Clinical Trial.
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.
Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS. Williamson PR, et al. Among authors: molloy sf. Nat Rev Neurol. 2017 Jan;13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016 Nov 25. Nat Rev Neurol. 2017. PMID: 27886201 Review.
Hope and parenting.
Cole BP, Molloy S. Cole BP, et al. Among authors: molloy s. Curr Opin Psychol. 2023 Feb;49:101554. doi: 10.1016/j.copsyc.2022.101554. Epub 2022 Dec 27. Curr Opin Psychol. 2023. PMID: 36669251 Review.
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team. Molloy SF, et al. N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922. N Engl J Med. 2018. PMID: 29539274 Free article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
Parkinson's families project: a UK-wide study of early onset and familial Parkinson's disease.
Towns C, Fang ZH, Tan MMX, Jasaityte S, Schmaderer TM, Stafford EJ, Pollard M, Tilney R, Hodgson M, Wu L, Labrum R, Hehir J, Polke J, Lange LM, Schapira AHV, Bhatia KP; Parkinson’s Families Project (PFP) Study Group; Global Parkinson’s Genetics Program (GP2); Singleton AB, Blauwendraat C, Klein C, Houlden H, Wood NW, Jarman PR, Morris HR, Real R. Towns C, et al. NPJ Parkinsons Dis. 2024 Oct 17;10(1):188. doi: 10.1038/s41531-024-00778-z. NPJ Parkinsons Dis. 2024. PMID: 39420034 Free PMC article.
Pneumolysin: stimulating protection.
Molloy S. Molloy S. Nat Rev Microbiol. 2011 Jan;9(1):4. doi: 10.1038/nrmicro2497. Nat Rev Microbiol. 2011. PMID: 21204310 No abstract available.
MxiC: the gatekeeper.
Molloy S. Molloy S. Nat Rev Microbiol. 2010 Dec;8(12):840. doi: 10.1038/nrmicro2488. Nat Rev Microbiol. 2010. PMID: 21125704 No abstract available.
A common complaint… a rare disease!
Toner MB, Molloy S, Mallett P, Thompson A, Speirs L. Toner MB, et al. Among authors: molloy s. Arch Dis Child Educ Pract Ed. 2022 Aug;107(4):268-270. doi: 10.1136/archdischild-2020-320122. Epub 2020 Nov 10. Arch Dis Child Educ Pract Ed. 2022. PMID: 33172868
323 results